About Sementis

Sementis is an Australian unlisted public biotechnology company based in Adelaide, South Australia that is dedicated to the research and development of new vaccines to tackle the world’s most challenging diseases. Sementis R&D is based in the UniSA Bradley Building within the state of the art Adelaide BioMed City Precinct.

It was founded in 2009, based on the invention of the Sementis Copenhagen Vector (SCV) platform system.


Research and development

Academic Collaborators

Board of Directors


Financial Publications